Vanguard Capital Management’s SpyGlass Pharma SGP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$17.2M Buy
660,821
+226,398
+52% +$5.58M ﹤0.01% 2473
2026
Q2
$9.7M Sell
434,423
-390
-0.1% -$8.46K ﹤0.01% 2834
2026
Q1
$11.3M Buy
+434,813
New +$11.7M ﹤0.01% 2667

Other funds holding SGP

Vanguard Capital Management's SGP Position: Q3 2026 in Review

Vanguard Capital Management increased its SpyGlass Pharma (SGP) stake by 52% in Q3 2026, buying an estimated $5.58M and bringing the position to 660,821 shares worth $17.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2473.

Vanguard Capital Management first reported a position in SGP in Q1 2026 and has held it in 3 quarters since. 70 funds tracked by Wall St. Rank hold SGP as of Q3 2026.

  • Vanguard Capital Management held 660,821 shares of SpyGlass Pharma worth $17.2M as of Q3 2026.
  • Vanguard Capital Management bought 226,398 SpyGlass Pharma shares in Q3 2026, an estimated $5.58M.
  • SpyGlass Pharma made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2473 holding.
  • Vanguard Capital Management first reported a position in SpyGlass Pharma in Q1 2026 and has held it in 3 quarters since.
  • 70 funds tracked by Wall St. Rank held SpyGlass Pharma as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.